NXS 3.13% 33.0¢ next science limited

Charts NXS, page-12

  1. 275 Posts.
    lightbulb Created with Sketch. 58
    NXS are developing a unique patented technology to fight against biofilm and they already have 4 FDA approvals in place....their technology has massive upside potential and it has so far been one of the most promising IPOs of this year given their unique medical sciences innovation and efficacy related to their treatment options.
    Therefore, for the above reasons and many others, I have a strong feeling about the long term potential of this stock and it is my favourite one so far for this year.
    Trust this addresses your queries.
    Cheers
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
33.0¢
Change
0.010(3.13%)
Mkt cap ! $96.25M
Open High Low Value Volume
33.0¢ 33.0¢ 33.0¢ $5.142K 15.58K

Buyers (Bids)

No. Vol. Price($)
2 15582 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 4499 1
View Market Depth
Last trade - 16.10pm 03/05/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.